Tianjin Venture Capital
88
3M
83
4.19
8
0.06
20
- Areas of investment
Summary
The venture was found in Asia in China. The main office of represented VC is situated in the Tianjin.
Among the most successful fund investment fields, there are Information Technology, Hardware. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Zhongyiming Technology, RaySea, BeagleData.
The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2016.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Tianjin Venture Capital, startups are often financed by Broadband Capital Investments. The meaningful sponsors for the fund in investment in the same round are Midas Capital, LeoGroup, Fortune Venture Capital. In the next rounds fund is usually obtained by Translink Capital, Yonghua Capital, New Oriental Education & Technology.
Investments analytics
Analytics
- Total investments
- 88
- Lead investments
- 8
- Exits
- 20
- Rounds per year
- 4.19
- Follow on index
- 0.06
- Investments by industry
- Manufacturing (25)
- Health Care (13)
- Information Technology (11)
- Industrial (11)
- Biotechnology (10) Show 100 more
- Investments by region
-
- China (84)
- United States (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 12M
- Group Appearance index
- 0.24
- Avg. company exit year
- 13
- Avg. multiplicator
- 1.25
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Effect Biotech | 15 May 2024 | Early Stage Venture | 4M | Shenzhen, Guangdong, China | |
| Shanghai Medicilon | 01 Apr 2010 | Early Stage Venture | 1M | Shanghai, Shanghai, China | |
| terminus | 04 May 2016 | Software, Information Technology, Information Services | Seed | 463K | Zhejiang, Shangcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.